The urgency behind the work is grounded in sobering epidemiology. Although cervical cancer is one of the most preventable malignancies, thanks to widespread screening since the 1940s and the availability of the HPV vaccine, more than 4,000 American women still die from the disease each year. The burden falls unevenly. In Harris County, Texas, which encompasses Houston, African American women experience a cervical cancer mortality rate of 3.7 per 100,000, higher than that of White women at 2.5 per 100,000 and higher than all other racial and ethnic minorities in the county. Harris County has also been identified as a hot spot for late-stage diagnoses, meaning women there are more likely than those elsewhere to learn they have cervical cancer only after it has advanced, when treatment options narrow and survival odds decline.

Why these disparities persist is a question of layered barriers rather than a single failure. Prior research points to poor health literacy, socioeconomic constraints, insurance gaps, language barriers, and a well-documented distrust of the healthcare system. Cultural attitudes, fear, and poor communication with providers compound the problem. Using nationally representative survey data, one research group found that African American women were significantly less likely than White women to have heard of HPV, to have received a provider recommendation for Pap screening, or to follow up after abnormal results. These inequities are shaped further by the intersection of race, gender, and socioeconomic status, factors that determine not only who gets screened but who gets called back, treated, and cured.

The intervention at the heart of the new study, called the Get Your Pap! Edutainment Webisode, departs deliberately from didactic public health messaging. Edutainment, the use of entertainment media to educate, has a long pedigree in health promotion, from fotonovelas used with Hispanic populations to short films deployed among Muslim women in Thailand. But few such interventions have been tailored specifically for African American women in a specific environmental context, such as a large urban southern metropolis. The Houston team set out to fill that gap with a live-action dramedy grounded in a behavioral theory rather than intuition alone.

That theory is the Information-Motivation-Behavioral Skills model, which holds that positive preventive behavior requires accurate information, motivation arising from personal and social influences, and the practical skills to act. The webisode maps each component onto its narrative. Two African American sisters, one a registered nurse, converse about scheduling Pap tests while waiting for an Uber. The younger sister voices misconceptions, including the belief that she is too young to worry about cancer screening, and the older sister corrects the misinformation and answers questions about HPV, the HPV vaccine, and the anxiety surrounding the Pap test. Humor, playful slang, brief animations, and a comedic gameshow segment that breaks the fourth wall keep viewers engaged, while a storyline involving a previous abnormal Pap result adds emotional weight. The film ends with the older sister booking her appointment and sharing her gynecologist’s contact information with her younger sibling.

The content itself was not improvised. The research team derived the webisode’s themes from a previously published concept mapping study that graphically modeled the health, behavioral, and cultural information most likely to increase screening intentions among African American women. Working closely with a production company, the investigators ensured that the script reflected those mapped domains, and three independent researchers with expertise in cancer prevention among minority populations vetted the film for cultural appropriateness before the final six-minute cut was produced.

To test the concept, the team enrolled forty African American women aged 21 to 52, with a mean age of 35.7 years, recruited over twelve weeks through community bulletin boards, churches, public events, and four community partner organizations. Participants completed a pre-test survey, watched the webisode online, and completed a post-test one week later, receiving a $45 e-gift card for full participation. Feasibility was assessed against explicit benchmarks covering recruitment, intervention delivery, retention, and acceptability. The results were striking: 46 women were screened for eligibility, yielding an 87 percent eligibility rate, and every single participant watched the entire film, with no dropouts. Ninety-five percent of participants were enrolled within the first ten weeks, and retention reached 100 percent at two and a half weeks with the help of two automated reminder emails.

The proof-of-concept outcomes were equally encouraging. Mean cervical cancer prevention knowledge rose from 4.7 to 6.8 on a ten-item index, a difference that was highly statistically significant. Intentions to obtain cervical cancer screening climbed from 2.5 to 3.9 on a five-point scale, and among the six participants within the recommended HPV vaccination age range, vaccination intentions rose from 3.3 to 4.1. Susceptibility items showed dramatic shifts. Before watching the film, only 6 percent of participants correctly answered that a single instance of sex is enough to transmit HPV; afterward, 91 percent did. The proportion who correctly recognized that African American women are roughly 75 percent more likely to die of cervical cancer than some other groups jumped from 35 percent to 88 percent, and knowledge that about 94 percent of cervical cancer is preventable in this population rose from under 18 percent to 65 percent. On acceptability, 87 percent of participants said they knew more about cervical cancer after watching, 80 percent reported feeling more at ease about getting a Pap test, and 81 percent believed there should be more discussion of cervical cancer in social media spaces.

The researchers are careful to frame these findings appropriately. This was a single-arm feasibility and proof-of-concept study without a control group, and the large effect sizes observed, while statistically significant, are prone to overestimation in small samples because random sampling variation can inflate apparent effects. The study does not establish efficacy or effectiveness, and intentions do not always translate into behavior, a well-documented gap in cancer screening research where intentions account for only about 30 percent of screening variance. The sample, drawn from three underserved Houston neighborhoods, was also relatively well educated and mostly insured, limiting generalizability to the women facing the greatest structural barriers. Notably, an exploratory analysis found that among unscreened women, younger participants tended not to know screening was required, while older women reported never having been advised by a doctor, suggesting that messaging may need to address different barriers at different life stages.

Even with those caveats, the implications are considerable. A brief webisode is cheap to disseminate once produced, imposes minimal burden on staff, and can be viewed on any personal device whenever the viewer prefers, making it attractive for resource-constrained community settings and for pairing with digital health platforms. It could also reach women who never hear a provider’s recommendation in the first place, a gap the unscreened participants’ own reports made painfully visible. The Houston team now plans a controlled pilot study, followed by a randomized controlled trial with longer follow-up, more diverse recruitment, and hard behavioral endpoints such as whether participants actually book and complete screening within six months. If those trials confirm what this early signal suggests, the humble format of two sisters talking in a living room may prove that sometimes the most effective medical intervention is a good story told well.

Subject of Research: A culturally tailored edutainment webisode intervention for cervical cancer prevention among African American women in Houston, Texas

Article Title: Feasibility and proof-of-concept of a cervical cancer prevention edutainment webisode for African American women in Houston, Texas

Article References: Carmack, C., Ahmed, N., Marinoni, A., Ousley, T., & Roncancio, A. (2026). Feasibility and proof-of-concept of a cervical cancer prevention edutainment webisode for African American women in Houston, Texas. International Journal of Public Health, 71, Article 1609804. https://doi.org/10.3389/ijph.2026.1609804

Image Credits: AI Generated

DOI: 10.3389/ijph.2026.1609804

Keywords: cervical cancer, edutainment, African American women, HPV, Pap test, cancer screening, health disparities, public health, Houston, IMB model, health communication, intervention study

The study, conducted by researchers affiliated with Moffitt Cancer Center in collaboration with CAN Community Health, a Ryan White-funded clinic network predominantly based in Florida, was published in the journal Cancer Causes & Control. It set out to identify the sociodemographic, health, and social predictors of anal and cervical cancer screening uptake among adults with and without HIV. The stakes are considerable: high-risk HPV causes more than ninety percent of anal and cervical cancers, and people with HIV are roughly seventeen times more likely to develop anal cancer than people without the virus, while women with HIV face about a fourfold increase in cervical cancer risk. HIV-related immunosuppression allows HPV infection to persist and progress more readily toward malignancy, and health system barriers contribute to later-stage diagnoses and higher mortality among this population.

Both anal and cervical cancers are unusual among malignancies in that they progress through well-defined, detectable precancerous lesions. Removing high-grade squamous intraepithelial lesions can halt progression before invasive cancer develops, which makes screening an unusually powerful prevention tool. For cervical cancer, established guidelines exist: the U.S. Preventive Services Task Force recommends screening every three years for women without HIV aged 21 to 65, while the Infectious Diseases Society of America advises annual screening for women with HIV beginning at age 21. Anal cancer screening guidance is more recent. The landmark ANCHOR study showed that treating anal high-grade lesions in people with HIV significantly reduced anal cancer incidence compared with active monitoring, and those findings underpin the International Anal Neoplasia Society consensus guidelines, which recommend screening for HIV-positive men who have sex with men and transgender women aged 35 and older, and for HIV-negative people in high-risk groups aged 45 and older.

To measure how these recommendations translate into real-world care, the research team implemented a cross-sectional survey between April and June 2024 among adult patients of the CAN clinic network, which serves more than 31,100 unique patients annually, a population that is 35 percent White, 35 percent Black, and 18 percent Hispanic or Latino. The questionnaire, distributed anonymously through the clinic’s electronic patient intake system and offered in English and Spanish, collected information on demographics, health history, cancer prevention behaviors, experiences with the health system, and social exposures including HIV-related stigma. Participants received a twenty-five dollar gift card. From the responses, 412 participants were eligible for anal cancer screening and 294 women were eligible for cervical cancer screening based on current guidelines.

The characteristics of the two screening-eligible groups reflected the populations most at risk. Among those eligible for anal cancer screening, the median age was 56 years, 88.8 percent were living with HIV, and 82.3 percent were men, with roughly two-thirds identifying as gay or lesbian. Among women eligible for cervical cancer screening, the median age was 38 and 43.5 percent were living with HIV. The researchers computed adjusted prevalence ratios using multivariable Poisson regression, guided by the Andersen Behavioral Model of health services use, with models stratified by HIV status and sex to account for documented differences in cancer risk and screening outcomes across these subpopulations.

The anal cancer findings delivered a cautiously optimistic signal. Overall, 58.6 percent of screening-eligible participants reported ever having been screened, most commonly through an anal Pap test or high-resolution anoscopy. After statistical adjustment, men with HIV were 57 percent more likely to have received anal cancer screening than men without HIV. Within the group of men with HIV, uptake was higher among those who had been diagnosed with any precancer and those living with three or more comorbidities, a pattern the authors attribute to more frequent medical encounters creating more opportunities for preventive services. Living in a household of three or more people was associated with significantly lower uptake among these men, possibly reflecting caregiving responsibilities, competing demands, or limited economic means that crowd out preventive visits.

The cervical cancer picture was far less reassuring. Only 47 percent of women with HIV had received guideline-adherent cervical screening, compared with 71 percent of women without HIV, a gap that persisted after adjustment, leaving women with HIV 40 percent less likely to be screened on time. This shortfall is particularly troubling because U.S. guidelines call for more frequent, annual screening in this higher-risk group, not less. The study also identified a psychosocial driver: among women with HIV, greater concerns about disclosing their HIV status were independently associated with lower guideline-adherent cervical screening uptake. This finding reinforces a growing body of evidence that stigma is not merely an abstract social burden but a concrete mechanism that undermines preventive care, engagement with health services, and trust in medical systems.

The researchers point to several practical implications. Community-based, culturally sensitive screening programs embedded in clinics that patients already trust appear to pay dividends, and the integrated social services offered by Ryan White-funded networks may help explain why anal cancer screening among men with HIV exceeded that of their HIV-negative counterparts. For cervical cancer, proven strategies exist to close the gap, including provider reminders, patient education campaigns, and HPV self-collection kits that can overcome geographic barriers, limited access, and the discomfort or stigma associated with pelvic examinations. The authors also note that clinician awareness matters, since gaps in provider knowledge and training about screening recommendations for people with HIV remain documented barriers alongside fragmented care, unstable housing, and transportation difficulties.

The study carries limitations worth noting. It was conducted within a single, highly diverse clinic network in Florida, so results may not generalize everywhere; it captured only patient-reported characteristics rather than provider-level factors; it assessed Pap testing rather than high-risk HPV testing for cervical screening adherence; and its cross-sectional design precludes conclusions about cause and effect, including the timing of precancer diagnoses relative to screening. Small sample sizes in some stratified models may also have limited statistical power. Still, the divergent findings, with anal screening lagging among women even as it advances among men, and cervical screening falling short precisely among the women who need it most, offer clinicians and public health planners a specific map of where targeted interventions, from stigma reduction to self-sampling, could save lives among one of the nation’s most cancer-vulnerable populations.

Subject of Research: Predictors of anal and cervical cancer screening uptake among adults with and without HIV

Article Title: Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network

Article References: Lin, Y. C., Hume, E., Boxtha, C., Commaroto, S. A., Lael, M., Christy, S. M., Vadaparampil, S. T., Giuliano, A. R., Coghill, A. E., Schabath, M. B., Vidrine, D. J., Peterson, J., DiPalmo, S., Joshi, H., Shukla, P., Vidrine, J. I., & Islam, J. Y. (2026). Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network. Cancer Causes & Control, 37(10), Article 159. https://doi.org/10.1007/s10552-026-02239-9

Image Credits: AI Generated

DOI: 10.1007/s10552-026-02239-9

Keywords: HIV, anal cancer screening, cervical cancer screening, HPV, cancer prevention, health disparities, HIV stigma, Pap test, community health clinics, guideline adherence, Cancer Causes & Control, Ryan White clinics